Position in ABT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$681,638
-$23,191 QoQ
Shares Held
7,512
+9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,694
of 2,959 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $1,445,210 across 2 Medical Devices names. ABT ranks #2 (47.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
8,441 | $763,572 | |
| 2 | ABT |
Abbott Laboratories
This page
|
7,512 | $681,638 |
All Filings in ABT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $681,638 | 7,512 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $704,829 | 6,865 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,617,118 | 12,907 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,783,545 | 13,316 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $3,386,512 | 24,899 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,306,035 | 24,923 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,576,645 | 22,780 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,826,782 | 16,023 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,851,572 | 17,819 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,983,480 | 17,451 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,998,430 | 18,156 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,625,724 | 16,786 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,821,070 | 16,704 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,647,702 | 16,272 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||